Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

This study has been terminated.
(Insufficient recruitment)
Sponsor:
Information provided by (Responsible Party):
Alberto Sanchez-Fueyo, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT01445236
First received: September 29, 2011
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)